Diagnostic utility of GenoType MTBDRsl assay for the detection of moxifloxacin-resistant mycobacterium tuberculosis, as compared to phenotypic method and whole-genome sequencing

Diagnostic utility of GenoType MTBDRsl assay for the detection of moxifloxacin-resistant mycobacterium tuberculosis, as compared to phenotypic method and whole-genome sequencing

Background: Recently, moxifloxacin (MFX)-resistant results of Mycobacterium tuberculosis (Mtb) obtained by GenoType MTBDRsl (second-line line probe assay [SL-LPA]) have been stratified to determine their resistance level; however, its accuracy has not been well studied. Therefore, the study aimed to...

Full description

Bibliographic Details
Main Authors:	Raj Narayan Yadav, Manpreet Bhalla, Gavish Kumar, Grish C Sah, Ravindra Kumar Dewan, Ritu Singhal
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2022-01-01
Series:	International Journal of Mycobacteriology
Subjects:	clinical breakpoint critical concentration drug-resistant tuberculosis moxifloxacin whole-genome sequencing
Online Access:	http://www.ijmyco.org/article.asp?issn=2212-5531;year=2022;volume=11;issue=2;spage=183;epage=189;aulast=Yadav

Similar Items

Moxifloxacin Induced Acute Delirium with Visual Hallucinations
by: Ergenekon Karagoz, et al.
Published: (2015-09-01)

Moxifloxacin-warfarin interaction
by: Yan Ji, et al.
Published: (2012-01-01)

Application of intracameral moxifloxacin to prevent endophthalmitis in cataract surgery
by: Servet Cetinkaya, et al.
Published: (2015-10-01)

Study of effectiveness of enrofloxacin and moxifloxacin in experimental salmonellosis of chickens
by: Skvortsov Vladimir, et al.
Published: (2021-01-01)

Detection of drug-resistant mycobacterium tuberculosis strains isolated in Serbia by the GenoType MTBDRsl assay
by: Živanović Irena, et al.
Published: (2012-01-01)

Moxifloxacin-induced acute psychosis: A case report with literature review
by: Faizan Mazhar, et al.
Published: (2016-01-01)

Intravitreal moxifloxacin injections in acute post-cataract surgery endophthalmitis: Efficacy and safety
by: Abhishek Agarwal, et al.
Published: (2021-01-01)

Pleural fluid penetration of moxifloxacin and doripenem: An experimental model of empyema
by: Mustafa Calik, et al.
Published: (2020-03-01)

Comparison of Tobramycin and Moxifloxacin eye drops in acute bacterial conjunctivitis: An open label randomized controlled institutional study from Kolkata
by: Prithwijit Banerjee, et al.
Published: (2020-12-01)

The effectiveness of moxifloxacin in the treatment of community-acquired pneumonia
by: Dmytro Dmytriiev, et al.
Published: (2021-11-01)

Moxifloxacin Induced Seizures -A Case Report.
by: Jiana Shi, et al.
Published: (2014-09-01)

A Case Report of Severe Corneal Toxicity following 0.5% Topical Moxifloxacin Use
by: A.P. Vignesh, et al.
Published: (2015-02-01)

The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure in Helicobacter pylori Eradication
by: Soohoon Kwon, et al.
Published: (2017-08-01)

Effects of moxifloxacin exposure on the conjunctival flora and antibiotic resistance profile following repeated intravitreal injections
by: Mustafa Ataş, et al.
Published: (2014-10-01)

Moxifloxacin is an effective and safe candidate agent for tuberculosis treatment: a meta-analysis
by: Ping Xu, et al.
Published: (2017-07-01)

Moxifloxacin and Sulfamethoxazole-Based Nanocarriers Exhibit Potent Antibacterial Activities
by: Noor Akbar, et al.
Published: (2021-08-01)

Moxifloxacin Activates the SOS Response in <i>Mycobacterium tuberculosis</i> in a Dose- and Time-Dependent Manner
by: Angelo Iacobino, et al.
Published: (2021-01-01)

Disposition kinetics of long acting moxifloxacin following intravenous administration in Sheep
by: Chirag M. Modi, et al.
Published: (2012-01-01)

Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA
by: Lisa Trieu, et al.
Published: (2015-03-01)

Safety of Moxifloxacin following repeated intramuscular administration in Wistar rats
by: K.A. Sadariya, et al.
Published: (2010-01-01)

Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI)
by: Chuchalin Alexander, et al.
Published: (2013-01-01)

Effect of moxifloxacin administration on pharmacokinetics of tolfenamic acid in rats
by: Satish D. Patel, et al.
Published: (2011-08-01)

Influence of Type and Neutralisation Capacity of Antacids on Dissolution Rate of Ciprofloxacin and Moxifloxacin from Tablets
by: Alija Uzunović, et al.
Published: (2009-02-01)

Comparison of the in vitro antibacterial activity of ofloxacin, levofloxacin, moxifloxacin, sitafloxacin, finafloxacin, and delafloxacin against Mycobacterium tuberculosis strains isolated in China
by: Yaoyao Kong, et al.
Published: (2023-11-01)

Two Eco-Friendly Chromatographic Methods Evaluated by GAPI for Simultaneous Determination of the Fluoroquinolones Moxifloxacin, Levofloxacin, and Gemifloxacin in Their Pharmaceutical Products
by: Eman A. Abdel Hameed, et al.
Published: (2022-10-01)

Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis
by: Bhavya Vishwa, et al.
Published: (2021-01-01)

Formulation and Evaluation of Moxifloxacin Loaded Bilosomes In-Situ Gel: Optimization to Antibacterial Evaluation
by: Ameeduzzafar Zafar, et al.
Published: (2022-07-01)

Simultaneous determination of moxifloxacin and cefixime by first and ratio first derivative ultraviolet spectrophotometry
by: Attimarad Mahesh, et al.
Published: (2012-09-01)

Second-line Drug Resistance Characterization in Mycobacterium tuberculosis by Genotype MTBDRsl Assay
by: Sunil Sethi, et al.
Published: (2020-01-01)

Cost analysis of GenoType® MTBDRplus and GenoType® MTBDRsl at the State Laboratory of São Paulo, Brazil
by: Lida Jouca de Assis Figueredo, et al.
Published: (2023-07-01)

Simultaneous determination of moxifloxacin and H2 receptor antagonist in pharmaceutical dosage formulations by RP-HPLC: application to in vitro drug interactions
by: Najma Sultana, et al.
Published: (2011-01-01)

Eco-friendly fluorimetric approaches for the simultaneous estimation of the co-administered ternary mixture: etoposide, moxifloxacin and nalbuphine
by: M. M. Tolba, et al.
Published: (2021-09-01)

Sensitive Determination of Moxifloxacin HCl in Pharmaceuticals or Human Plasma Using Luminescence or Eye Vision
by: Gasser M. Khairy, et al.
Published: (2022-09-01)

Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials
by: Qiaoling Ruan, et al.
Published: (2016-01-01)

Comparative effect of ciprofloxacin and moxifloxacin on the modulation of bile acid profiles and gut microbiota in rats
by: Meng-Meng Wang, et al.
Published: (2022-08-01)

Diagnostic Performance of the GenoType MTBDRplus and MTBDRsl Assays to Identify Tuberculosis Drug Resistance in Eastern China
by: Qiao Liu, et al.
Published: (2017-01-01)

A typical presentation of moxifloxacin-induced DRESS syndrome with pulmonary involvement: a case report and review of the literature
by: Yinhong Zhang, et al.
Published: (2022-07-01)

Data in Brief of: Clinical benefits of moxifloxacin as initial treatment of community-acquired pneumonia: Data from meta-analyses
by: Xiwen Du, et al.
Published: (2021-10-01)

Mycobacterium smegmatis strains genetically resistant to moxifloxacin emerge de novo from the moxifloxacin-surviving population containing high levels of superoxide, H2O2, hydroxyl radical, and Fe (II)
by: Avraneel Paul, et al.
Published: (2022-01-01)

Evaluation of cardiac arrhythmia incidence in patients treated with oral moxifloxacin
by: Casit Olgun Celik, et al.
Published: (2019-01-01)